Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 93

1.

Rituximab in critically ill patients.

Dimopoulos G, Armaganidis A, Poulakou G, Matthaiou DK.

Minerva Anestesiol. 2013 Feb;79(2):185-93. Epub 2012 Nov 8. Review.

PMID:
23135691
2.

Repeated course of rituximab for treatment of nephrotic syndrome in patients with chronic GVHD.

Mellon-Reppen S, Ratanatharathorn V, Cronin S, Uberti JP.

Bone Marrow Transplant. 2010 Dec;45(12):1758-9. doi: 10.1038/bmt.2010.58. Epub 2010 Apr 12. No abstract available.

PMID:
20383208
3.

Rituximab.

Borker A, Choudhary N.

Indian Pediatr. 2011 Aug;48(8):627-32. Review.

PMID:
21918268
4.

Rituximab administration within 6 months of T cell-depleted allogeneic SCT is associated with prolonged life-threatening cytopenias.

McIver Z, Stephens N, Grim A, Barrett AJ.

Biol Blood Marrow Transplant. 2010 Nov;16(11):1549-56. doi: 10.1016/j.bbmt.2010.05.004. Epub 2010 May 24.

5.

Rituximab and its use in autoimmune bullous disorders.

Daniel BS, Murrell DF, Joly P.

Dermatol Clin. 2011 Oct;29(4):571-5. doi: 10.1016/j.det.2011.06.023.

PMID:
21925000
6.

Weekly rituximab followed by monthly rituximab treatment for steroid-refractory chronic graft-versus-host disease: results from a prospective, multicenter, phase II study.

Kim SJ, Lee JW, Jung CW, Min CK, Cho B, Shin HJ, Chung JS, Kim H, Lee WS, Joo YD, Yang DH, Kook H, Kang HJ, Ahn HS, Yoon SS, Sohn SK, Min YH, Min WS, Park HS, Won JH.

Haematologica. 2010 Nov;95(11):1935-42. doi: 10.3324/haematol.2010.026104. Epub 2010 Jul 27.

7.

Rituximab in dermatology.

España A, Ornilla E, Panizo C.

Actas Dermosifiliogr. 2013 Jun;104(5):380-92. doi: 10.1016/j.adengl.2013.04.002. Epub 2013 May 10. Review. English, Spanish.

PMID:
23665436
8.

Monoclonal antibodies to treat graft-versus-host disease.

Carella AM, D'Arena G, Cascavilla N.

Mini Rev Med Chem. 2011 Jun;11(6):473-9. Review.

PMID:
21561410
9.

Rituximab in the treatment of bullous systemic lupus erythematosus.

Alsanafi S, Kovarik C, Mermelstein AL, Werth VP.

J Clin Rheumatol. 2011 Apr;17(3):142-4. doi: 10.1097/RHU.0b013e318214f30c.

PMID:
21441817
10.

Emerging role of CD20 blockade in allogeneic hematopoietic cell transplantation.

Kharfan-Dabaja MA, Bazarbachi A.

Biol Blood Marrow Transplant. 2010 Oct;16(10):1347-54. doi: 10.1016/j.bbmt.2010.01.005. Epub 2010 Jan 18. Review.

11.

Rituximab for autoimmune blistering diseases: recent studies, new insights.

Lunardon L, Payne AS.

G Ital Dermatol Venereol. 2012 Jun;147(3):269-76.

12.

Treatment of chronic steroid-refractory graft-versus-host disease with low-dose rituximab.

von Bonin M, Oelschlägel U, Radke J, Stewart M, Ehninger G, Bornhauser M, Platzbecker U.

Transplantation. 2008 Sep 27;86(6):875-9. doi: 10.1097/TP.0b013e318183f662.

PMID:
18813113
13.

Prospective data collection of off-label use of rituximab in Australian public hospitals.

O'Connor K, Liddle C.

Intern Med J. 2013 Aug;43(8):863-70. doi: 10.1111/imj.12206.

PMID:
23735074
14.

Rituximab for the treatment of corticosteroid-refractory chronic graft-versus-host disease.

Teshima T, Nagafuji K, Henzan H, Miyamura K, Takase K, Hidaka M, Miyamoto T, Takenaka K, Akashi K, Harada M.

Int J Hematol. 2009 Sep;90(2):253-60. doi: 10.1007/s12185-009-0370-x. Epub 2009 Jun 20.

PMID:
19543951
15.

Off-label use of rituximab in a tertiary Queensland hospital.

Butterly SJ, Pillans P, Horn B, Miles R, Sturtevant J.

Intern Med J. 2010 Jun;40(6):443-52. doi: 10.1111/j.1445-5994.2009.01988.x. Epub 2009 May 21.

PMID:
19460062
16.

Use of intravenous immunoglobulin to treat chronic bilateral otomastoiditis in the setting of rituximab induced hypogammaglobulinemia.

Otremba MD, Adam SI, Price CC, Hohuan D, Kveton JF.

Am J Otolaryngol. 2012 Sep-Oct;33(5):619-22. doi: 10.1016/j.amjoto.2012.01.006. Epub 2012 Feb 21.

PMID:
22361345
17.

Does rituximab increase the incidence of infectious complications? A narrative review.

Kelesidis T, Daikos G, Boumpas D, Tsiodras S.

Int J Infect Dis. 2011 Jan;15(1):e2-16. doi: 10.1016/j.ijid.2010.03.025. Epub 2010 Nov 11. Review.

18.

Rituximab in bronchiolitis obliterans after haematopoietic stem cell transplantation.

Lorillon G, Robin M, Meignin V, Ribaud P, Lescoeur B, Gossot D, Socié G, Tazi A, Bergeron A.

Eur Respir J. 2011 Aug;38(2):470-2. doi: 10.1183/09031936.00003711. No abstract available.

19.

B-cell involvement in chronic graft-versus-host disease.

Kapur R, Ebeling S, Hagenbeek A.

Haematologica. 2008 Nov;93(11):1702-11. doi: 10.3324/haematol.13311. Epub 2008 Aug 25.

20.

Safety of rituximab in the treatment of B cell malignancies: implications for rheumatoid arthritis.

Hainsworth JD.

Arthritis Res Ther. 2003;5 Suppl 4:S12-6. Epub 2003 Dec 2. Review.

Supplemental Content

Support Center